IDH1 and glioma: In glioma patients, R132H-mutated IDH1 is spontaneously processed, and an immunodominant epitope in the p123-142 region of MHC class II molecules is presented to CD4+ T cells, inducing spontaneous mutation-specific TH1 polarization and generation of mutation-specific antibodies.